1 / 4

Global Neuropathic Pain Treatment Market, Size, Share, Analysis Report

The global neuropathic pain treatment market is estimated to grow at a CAGR of nearly 5.8% during the forecast period.

alfahadkhan2510
Download Presentation

Global Neuropathic Pain Treatment Market, Size, Share, Analysis Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Neuropathic Pain Treatment Market, Size, Share, Analysis Report & Forecast to 2026 Global Neuropathic Pain Treatment Market Size, Growth Analysis Report, Forecast to 2027 Global Neuropathic Pain Treatment Market Size, Growth Analysis Report, Forecast to 2027 Global Neuropathic Pain Treatment Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Neuropathic Pain Treatment Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 The global neuropathic pain treatment market is estimated to grow at a CAGR of nearly 5.8% during the forecast period. The major factors contributing to the growth of the market include increasing prevalence of diabetes and rising incidences of spinal cord injury. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. As of 2019, the estimated number of individuals suffering from spinal cord injury in the US is nearly 291,000. Nearly 78% of new incidences were reported among males. Free Sample Copy @ https://www.omrglobal.com/request-sample/neuropathic-pain- treatment-market

  2. Based on the effectiveness, tricyclic antidepressants tend to work effectively as compared to anticonvulsant (gabapentin). The most commonly used tricyclic antidepressants to treat neuropathic pain include desipramine, amitriptyline, nortriptyline, and imipramine. These drugs are effective norepinephrine reuptake inhibitors and thus, majorly supports in the treatment of neuropathic pain. The most common side-effect of tricyclic antidepressants includes constipation, dry mouth, somnolence, memory impairment, and weight gain. Less common side effects include cardiac arrhythmias, urinary retention, blurred vision, and orthostatic hypotension. A Full Report of Global Neuropathic Pain Treatment Market is Available at: https://www.omrglobal.com/industry-reports/neuropathic-pain-treatment-market Some common medications and patches are used to treat neuropathic pain caused by spinal cord injury include gabapentin (Neurontin), amitriptyline (Elavil), pregabalin (Lyrica), and lidocaine (Lidoderm). Lidocaine patches are utilized for pain relief from post-herpetic neuralgia. The patch works by stopping nerves from transmitting pain signals. Pregabalin (Lyrica) is an anticonvulsant drug which is indicated for the treatment of epilepsy and neuropathic pain. Pregabalin is a substitute treatment for patients with neuropathic pain that has not responded to other drug alternatives. Additionally, innovations in neurostimulation devices will likely offer an opportunity for more reliable and efficient treatment of neuropathic pain. Global Neuropathic Pain Treatment Market – Segmentation By Application •Food and Beverages •Chemical •Pharmaceutical •Others Global Neuropathic Pain Treatment Market – Segmentation by Region North America •United States •Canada Europe •Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China

  3. •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles • Abbott Laboratories • Acorda Therapeutics, Inc. • Assertio Therapeutics, Inc. • Astellas Pharma Inc. • AstraZeneca plc • Biogen Inc. • BioIntervene, Inc. • Boston Scientific Corp. • Cipla Ltd. •Dr. Reddy’s Laboratories Ltd. • Eli Lilly and Co. • GlaxoSmithKline plc • Glenmark Pharmaceuticals Ltd. • Grünenthal GmbH • Johnson & Johnson Services, Inc. • Lexicon Pharmaceuticals, Inc. • Lupin Ltd. • Medtronic plc • Pfizer Inc. • Sanofi S.A. • Teva Pharmaceutical Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neuropathic-pain-treatment-market

  4. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related